Citi Upgrades Medco Health Solutions (MHS) to Buy

April 22, 2008 9:06 AM EDT

Citi upgrades Medco Health Solutions (NYSE: MHS) from Hold to Buy. Price target $57.

Citi analyst says, "Favorable trends include: 1) Recent contract renewal of its most significant customer (UnitedHealth (NYSE: UNH)) making up 22% of 2007 total net revenues, 2) multi-year cycle of drug patent expirations and generic drug launches that are more profitable; 3) rising penetration of mail order pharmacy; 4) leading specialty pharmaceutical franchise Accredo Health; 5) visibility on strong EPS growth of 25%-27% in 2008, and we model ~16% long-term."

Medco Health Solutions Inc. (Medco) is a pharmacy benefit manager. The Company provides traditional and specialty prescription drug benefit programs and services for its clients and members. [SM]


Related Categories

Upgrades

Stocks Mentioned

MHS 26.25

-19.58 -42.72%
Volume: 437,190
Track MHS

UNH 26.31

+1.15 +4.57%
Volume: 433,844
Track UNH


Related Entities



Comments

UNH
LES on Apr 23, 2008 03:23 AM

I am contemplating invest right now in UNH . What do you think about my decission ? I am a newcommer so please do not ridicule me . Thanx, LES


Add Your Comment